Trends of HbA1c and BMI in People with Type 2 Diabetes: A Japanese Claims-Based Study

被引:3
|
作者
Hara, Kazuo [1 ]
Hirase, Tetsuaki [2 ]
Pathadka, Swathi [3 ]
Cai, Zhihong [2 ]
Sato, Manaka [2 ]
Ishida, Noriyuki [4 ]
Takemura, Ryo [4 ]
机构
[1] Jichi Med Univ, Dept Pulm Med, Saitama Med Ctr, Saitama, Japan
[2] Eli Lilly Japan KK, Japan Drug Dev & Med Affairs, Kobe, Japan
[3] Eli Lilly Serv India Pvt Ltd, Lilly Capabil Ctr India, Primrose 7B, Bengaluru 560103, Karnataka, India
[4] Keio Univ Hosp, Clin & Translat Res Ctr, Biostat Unit, Tokyo, Japan
关键词
Body Mass Index; Glycated hemoglobin; Japanese claims-based database; Obesity; Type; 2; diabetes; BODY-MASS INDEX; OBESITY; RISK; PREVALENCE; OVERWEIGHT; MELLITUS; CRITERIA; WORKERS; COHORTS;
D O I
10.1007/s13300-024-01543-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Obesity prevalence has increased in Japan in recent years. Given the strong association of obesity with poor glycemic control, and increased risk of type 2 diabetes (T2D) with central obesity, this study describes the current trends and relationships between glycated hemoglobin (HbA1c), body mass index (BMI), and waist circumference in the Japanese people with T2D. Methods: This was a retrospective, cross-sectional study of people with T2D who had at least one recorded HbA1c and BMI (or waist circumference) value in the Japan Medical Data Center Claims database. Five annual cohorts of the study population were formed between January 2017 and December 2021. Annual trends of HbA1c across BMI categories (obesity class I [>= 25 similar to < 30 kg/m(2)]-IV [>= 40 kg/m(2)]) and in people with central obesity (waist circumference: >= 85 cm in men; >= 90 cm in women) were described by sex and age groups. Results: Overall, 106,089 people with T2D (HbA1c and BMI data: 106,079; HbA1c and waist circumference data: 105,424) were included, with the majority of people belonging to obesity class I (range: 39.7-40.6%) and obesity class II (range: 16.2-17.7%) categories across all annual cohorts. People in higher BMI categories had higher mean HbA1c, with > 50% of people with T2D in obesity class I-IV (54.8-56.5%) having HbA1c >= 7%. Between 2017 and 2021, BMI and waist circumference increased in the age group 18-44 years. More than 50% of people with T2D and central obesity in both sexes and people of age group 18-44 years across obesity class I-IV or with central obesity had HbA1c >= 7%. Conclusion: More than half of the people with T2D belonging to obesity class I-IV or central obesity had poor glycemic control (HbA1c >= 7%), especially in the 18-44 age group. This highlights the need for body weight management for better glycemic control in relatively young Japanese people with T2D and obesity.
引用
收藏
页码:801 / 817
页数:17
相关论文
共 50 条
  • [21] Incidence of type 2 diabetes by HbA1c and OGTT: the Isfahan Diabetes Prevention Study
    Janghorbani, Mohsen
    Amini, Masoud
    ACTA DIABETOLOGICA, 2012, 49 : S73 - S79
  • [22] Incidence of type 2 diabetes by HbA1c and OGTT: the Isfahan Diabetes Prevention Study
    Mohsen Janghorbani
    Masoud Amini
    Acta Diabetologica, 2012, 49 : 73 - 79
  • [23] HbA1c and Risk of Severe Hypoglycemia in Type 2 Diabetes The Diabetes and Aging Study
    Lipska, Kasia J.
    Warton, E. Margaret
    Huang, Elbert S.
    Moffet, Howard H.
    Inzucchi, Silvio E.
    Krumholz, Harlan M.
    Karter, Andrew J.
    DIABETES CARE, 2013, 36 (11) : 3535 - 3542
  • [24] HbA1c and Risk of Severe Hypoglycemia in Type 2 Diabetes: The Diabetes & Aging Study
    Lipska, Kasia J.
    Warton, E. Margaret
    Huang, Elbert S.
    Moffet, Howard H.
    Inzucchi, Silvio E.
    Krumholz, Harlan M.
    Karter, Andrew J.
    DIABETES, 2013, 62 : A101 - A102
  • [25] INCIDENCE OF TYPE 2 DIABETES BY HBA1C AND OGTT: THE ISFAHAN DIABETES PREVENTION STUDY
    Janghorbani, M.
    Amini, M.
    JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 2011, 65 : A255 - A255
  • [26] A risk score of BMI, HbA1c and triglycerides predicts future glycemic control in type 2 diabetes
    Hertroijs, D. F. L.
    Elissen, A. M. J.
    Brouwers, M. C. G. J.
    Schaper, N. C.
    Kohler, S.
    Popa, M. C.
    Asteriadis, S.
    Hendriks, S. H.
    Bilo, H. J.
    Ruwaard, D.
    INTERNATIONAL JOURNAL OF INTEGRATED CARE, 2018, 18
  • [27] Influence of HbA1c and BMI on Lipid Trajectories in Youths and Young Adults With Type 1 Diabetes
    Katz, Michelle L.
    Kollman, Craig R.
    Dougher, Carly E.
    Mubasher, Mohamed
    Laffel, Lori M. B.
    DIABETES CARE, 2017, 40 (01) : 30 - 37
  • [28] The safety, efficacy and predictors for HbA1c reduction of sitagliptin in the treatment of Japanese type 2 diabetes
    Maeda, Hajime
    Kubota, Akira
    Tanaka, Yasushi
    Terauchi, Yasuo
    Matsuba, Ikuro
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2012, 95 (01) : E20 - E22
  • [29] Depressive symptoms and HbA1c in patients with Type 1 and Type 2 diabetes
    Kawada, T.
    DIABETIC MEDICINE, 2014, 31 (06) : 759 - 760
  • [30] The management of type 2 diabetes: Is HbA1c the only goal?
    Bauduceau, B.
    Bordier, L.
    Dupuy, O.
    Garcia, C.
    Mayaudon, H.
    MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2010, 34 (10): : 560 - 563